SysteMHC v.230601
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About
SYSMHCID Project name PubmedID DatasetID IEDB ID
SYSMHCID Project_name PubmedID DatasetID IEDB_ID
SYSMHC00001 An open-source computational and data resource to analyze digital maps of immunopeptidomes 26154972 PXD001872 1029446
SYSMHC00002 Immunopeptidome of THP1 cells unpublished unpublished unpublished
SYSMHC00003 Immunopeptidome of PBMCs isolated from healthy patients unpublished unpublished unpublished
SYSMHC00004 iRT-standardized immunopeptidome in JY and fibroblast cells unpublished unpublished unpublished
SYSMHC00005 Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation 25576301 PXD000394 1029742
SYSMHC00006 The human leukocyte antigen-presented ligandome of B lymphocytes 23481700 PASS00211 1029582
SYSMHC00007 HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 27412690 PXD003790 pending
SYSMHC00008 Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames 26728094 PXD001898 1029832
SYSMHC00009 Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides 24714562 PASS00270 1027559
SYSMHC00010 MHC class I-associated peptides derive from selective regions of the human genome 27841757 PXD004023 pending
SYSMHC00011 Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells 26467324 unpublished pending
SYSMHC00012 Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residue 24366607 PXD000450 1027269
SYSMHC00013 Comparative Analysis of the Endogenous Peptidomes Displayed by HLA-B27 and Mamu-B08: Two Class I Alleles Associated with Elite Control of HIV/SIV Infection 26811146 PXD004964 pending
SYSMHC00014 Arginine (Di)methylated Human Leukocyte Antigen Class I Peptides Are Favorably Presented by HLA-B*07 27503676 PXD004233 pending
SYSMHC00015 Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity 26764012 PXD002951 pending
SYSMHC00016 Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples 27452731 PXD002439 pending
SYSMHC00017 Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires 25502872 PXD001205 1029782
SYSMHC00018 A tissue-based draft map of the murine MHC class I immunopeptidome 30084848 PXD008733 1033621
SYSMHC00019 Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis 27726376 PXD003051 pending
SYSMHC00020 Synthetic Mtb class I peptides unpublished unpublished unpublished
SYSMHC00021 Synthetic EBV class I peptides unpublished unpublished unpublished
SYSMHC00022 Synthetic HLA class I peptides unpublished unpublished unpublished
SYSMHC00023 Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry 27869121 PXD004894 pending
SYSMHC00024 Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction 28228285 MSV000080527 1031481
SYSMHC00025 Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma 34391887 PXD022949 pending
SYSMHC00026 Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction 33845167 PXD022950 pending
SYSMHC00027 A large peptidome dataset improves HLA class I epitope prediction across most of the human population. 31844290 MSV000084172 1036600
SYSMHC00028 Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification 30556813 MSV000082648 1039102
SYSMHC00029 Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes 32157095 PXD013649 1036477
SYSMHC00030 MHC class I-associated peptides derive from selective regions of the human genome 27841757 PXD004023 1029054
SYSMHC00031 Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens 28329770 PXD004746, PXD005704 1031453
SYSMHC00032 The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing 28446606 PXD006215 1031897
SYSMHC00033 Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity 28832583 PXD005231 1032297
SYSMHC00034 Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires 28871256 PXD006534 1032172
SYSMHC00035 Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices 28904123 PXD009531 1032403
SYSMHC00036 The immunopeptidomic landscape of ovarian carcinomas 29093164 PXD007635 1033455
SYSMHC00037 High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome 29242379 PXD006939 1034943
SYSMHC00038 CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival 29490700 PXD008937 pending
SYSMHC00039 Comparison of the MHC I Immunopeptidome Repertoire of B-Cell Lymphoblasts Using Two Isolation Methods 29508533 PXD007935 1033402
SYSMHC00040 Improved Ribo-seq enables identification of cryptic translation events 29529017 PXD007203 pending
SYSMHC00041 Ranking the Contribution of Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Polymorphisms to Shaping the HLA-B*27 Peptidome 29632046 PXD008500 1033452
SYSMHC00042 Allele-specific Alterations in the Peptidome Underlie the Joint Association of HLA-A*29:02 and Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) with Birdshot Chorioretinopathy 29769354 PXD007679 1033564
SYSMHC00043 Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens 29786170 PXD009738 1033513
SYSMHC00044 Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma 30072578 PXD008127 pending
SYSMHC00045 HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome 30410026 PXD008570, PXD008571, PXD008572 1034317
SYSMHC00046 Pro-inflammatory Cytokines Alter the Immunopeptidome Landscape by Modulation of HLA-B Expression 30833945 PXD009935 1035955
SYSMHC00047 Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1) 31222486 PXD011766 1035504
SYSMHC00048 The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands 30429286 PXD009925 1034232
SYSMHC00049 Noncoding regions are the main source of targetable tumor-specific antigens 30518613 PXD009749, PXD009750, PXD009751, PXD009752, PXD009753, PXD009754, PXD009755 pending
SYSMHC00050 HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy 33858848 PXD019643, PXD020186 1036766
SYSMHC00051 MS-Rescue: A Computational Pipeline to Increase the Quality and Yield of Immunopeptidomics Experiments 30578603 PXD011723 pending
SYSMHC00052 Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations 35982173 JPST001068, JPST001069, JPST001072 pending
SYSMHC00053 MHCquant: Automated and Reproducible Data Analysis for Immunopeptidomics 31589052 PXD011628 pending
SYSMHC00054 Mass Spectrometry Based Immunopeptidomics Leads to Robust Predictions of Phosphorylated HLA Class I Ligands 31848261 PXD013831 1036421
SYSMHC00055 Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment 31735170 PXD014017 1035926
SYSMHC00056 B-cell lymphomas present immunoglobulin neoantigens 30545830 PXD010808 pending
SYSMHC00057 Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples 34391888 MSV000087743 pending
SYSMHC00058 Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma 30775418 PXD008984 pending
SYSMHC00059 Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs 34171305 MSV000087225 1037971
SYSMHC00060 Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome 31092671 PXD012348 1036212
SYSMHC00061 In-depth mining of the immunopeptidome of an acute myeloid leukemia cell line using complementary ligand enrichment and data acquisition strategies 32387766 PXD015039 1038663
SYSMHC00062 Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin 31291378 PXD012083 pending
SYSMHC00063 Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation 29789417 PXD009602 1034934
SYSMHC00064 Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides 35675780 MSV000084442 pending
SYSMHC00065 Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma 31039795 PXD013057 1034990
SYSMHC00066 Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes 31611696 PXD012308 pending
SYSMHC00067 The dominantly expressed class II molecule from a resistant MHC haplotype presents only a few Marek's disease virus peptides by using an unprecedented binding motif 33901176 PXD023954 pending
SYSMHC00068 Integral Use of Immunopeptidomics and Immunoinformatics for the Characterization of Antigen Presentation and Rational Identification of BoLA-DR-Presented Peptides and Epitopes 33789985 PXD024053 pending
SYSMHC00069 Profiling MHC II immunopeptidome of blood-stage malaria reveals that cDC1 control the functionality of parasite-specific CD4 T cells 28935714 PXD007628 1032520
SYSMHC00070 HLA-DQ8 Immunopeptidomics, Type 1 Diabetes Pending PXD019466 pending
SYSMHC00071 Membranal and Blood-Soluble HLA Class II Peptidome Analyses Using Data-Dependent and Independent Acquisition 29314611 MSV000081439 1033825
SYSMHC00072 Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells 28467828 PXD005935 1031891
SYSMHC00073 IFNγ Modulates the Immunopeptidome of Triple Negative Breast Cancer Cells by Enhancing and Diversifying Antigen Processing and Presentation 33968037 PXD023038,PXD023044 1040330
SYSMHC00074 Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference 32983136 PXD020011 1040274
SYSMHC00075 Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis 27726376 PXD003051 1031299
SYSMHC00076 CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens 33592498 PXD020079 1039604
SYSMHC00077 The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides 32152506 PXD015408,PXD015726 1037314
SYSMHC00078 Identification of bacteria-derived HLA-bound peptides in melanoma 33731925 PXD022150 1040043
SYSMHC00079 HLA class II immunopeptidomics reveals that co-inherited HLA-allotypes within an extended haplotype can improve proteome coverage for immunosurveillance 34357683 PXD025877 1039356
SYSMHC00080 Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction 31495665 PXD014293 pending
SYSMHC00081 Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin 32644114 PXD018151 pending
SYSMHC00082 Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes 37023751 PXD034773 pending
SYSMHC00083 Peptidomes and Structures Illustrate Two Distinguishing Mechanisms of Alternating the Peptide Plasticity Caused by Swine MHC Class I Micropolymorphism 33717070 PXD019523 1038493
SYSMHC00084 Identification of MHC-I-Presented Porcine Respiratory and Reproductive Syndrome Virus (PRRSV) Peptides Reveals Immunogenic Epitopes within Several Non-Structural Proteins Recognized by CD8+ T Cells 36146698 PXD035499 pending
SYSMHC00085 The length distribution of MHC-I binding peptides Pending PXD020818 pending
SYSMHC00086 Identification of blood MHC-binding peptides in mice Pending IPX0004248000 pending
SYSMHC00087 Profiling of HLA-I ligandomes discovers novel cervical cancer-associated antigens Pending IPX0006523000 pending
SYSMHC00088 The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy 30530751 PXD010450 pending
SYSMHC00089 Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes 33740418 PXD018542 pending